© 2018 by BunyaVax. 

Prestigious SME Instrument funding for BunyaVax

BunyaVax receives 50.000 euro from the European Commission (EC). The funding proposal of BunyaVax was selected out of hundreds of applications. The grant will be used to prepare the company for co-development partnerships and to upscale the manufacturing process of the Plug and Play vaccine technology. In February this year BunyaVax submitted its RAPID proposal under the Horizon 2020 SME Instrument scheme. RAPID is brief for RNA particles for Preparedness against Infectious Diseases. Within the scheme, European companies can apply for stage I (50k) or stage II (2.5 million) funding to bring highly innovative developments closer to market. Recently BunyaVax was informed by the EC that the RAP